Stock listing
ALLO Stock Price, News, Filings & Events — Allogene Therapeutics, Inc.
Selected listing: ALLO · NASDAQ · USD · US
This page tracks Allogene Therapeutics, Inc.'s ALLO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALLO:NASDAQ. ALLO:NASDAQ is the stock-level entry point for investors researching Allogene Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Allogene Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative therapies for cancer treatment. The company trades under the ticker ALLO and has a market capitalization of approximately $600.6 million. Allogene is dedicated to advancing its research and development efforts in the field of allogeneic cell therapy.
- Ticker
- ALLO:NASDAQ
- Asset type
- Stock
- Market cap
- $722.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Allogene Therapeutics, Inc. ALLO:NASDAQ stock context
This page tracks Allogene Therapeutics, Inc.'s ALLO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALLO:NASDAQ. ALLO:NASDAQ is the stock-level entry point for investors researching Allogene Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Allogene Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative therapies for cancer treatment. The company trades under the ticker ALLO and has a market capitalization of approximately $600.6 million. Allogene is dedicated to advancing its research and development efforts in the field of allogeneic cell therapy.
Latest news from Allogene Therapeutics, Inc.
Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update
August 12, 2026
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
August 4, 2026
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) a...
July 29, 2026
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remiss...
July 15, 2026
Allogene Therapeutics Announces Planned CEO Succession
May 28, 2026
Allogene Therapeutics, Inc. earnings calls
Allogene Therapeutics, Inc. (ALLO) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Allogene Therapeutics, Inc. (ALLO) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Allogene Therapeutics, Inc. (ALLO) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Allogene Therapeutics, Inc. (ALLO) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Allogene Therapeutics, Inc. (ALLO) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Allogene Therapeutics, Inc. (ALLO) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for ALLO:NASDAQ.
Allogene Therapeutics, Inc. company profile
View the public company page for Allogene Therapeutics, Inc. on 6ix.
Allogene Therapeutics, Inc. news
Read company news and market updates connected to Allogene Therapeutics, Inc..
Allogene Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Allogene Therapeutics, Inc..